MRI in McArdle Disease (GSDV)

MRI in McArdle Disease (Glycogen Storage Disease Type V)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03844022

Enrollment

Registered

2019-02-18

Start date

2018-03-01

Completion date

2021-02-01

Last updated

2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycogen Storage Disease Type V

Brief summary

The aim of this study is to describe the degree of muscle wasting in patients with McArdle disease judged by MRI, quantitative magnetic resonance (DIXON) and T1 weighted images, and muscle strength, collected across multiple European sites and compared to healthy controls.

Interventions

DIAGNOSTIC_TESTMRI

magnetic resonance imaging

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* GSDV or healthy controls

Exclusion criteria

* MRI contradictions

Design outcomes

Primary

Measure	Time frame	Description
DIXON MRI	1 time	Whole body quantitative muscle fat fraction analyses (DIXON)

Secondary

Measure	Time frame	Description
Muscle strength	1 time	MRC scale
T1 MRI	1 time	Whole body qualitative muscle fat fraction analyses (T1)
Back pain questionnaire	1 time	Back pain questionnaire

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026